• Gain insights from Phase 2a clinical data of AP-325 in neuropathic pain and its impact on patient outcomes
• Understand the next steps in clinical development and how this therapy could shape future treatment strategies
• Explore the potential of dual-target mechanisms to deliver more effective, long-term pain relief

New Data